Status:

COMPLETED

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Lead Sponsor:

Hoffmann-La Roche

Conditions:

Influenza

Eligibility:

All Genders

1-12 years

Phase:

PHASE4

Brief Summary

This study will evaluate the safety of Tamiflu, when used for the prevention of influenza in children during the flu season. Children who would benefit from influenza prophylaxis when influenza is cir...

Eligibility Criteria

Inclusion

  • males or females, 1-12 years of age;
  • candidate for seasonal prophylaxis;
  • negative rapid diagnostic test for influenza at baseline.

Exclusion

  • symptoms suggestive of influenza-like illness;
  • positive rapid diagnostic test for influenza;
  • antiviral treatment for influenza in 2 weeks prior to randomization.

Key Trial Info

Start Date :

December 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT00412555

Start Date

December 1 2006

End Date

May 1 2007

Last Update

August 18 2020

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

West Palm Beach, Florida, United States, 33409

2

Pittsburgh, Pennsylvania, United States, 15241

3

Jackson, Tennessee, United States, 38305

4

El Paso, Texas, United States, 79925